Your browser doesn't support javascript.
loading
Meta-analysis of gemcitabine plus nab-paclitaxel combined with targeted agents in the treatment of metastatic pancreatic cancer.
Li, Zhong-Hui; Ma, Yin-Jie; Jia, Zong-Hang; Weng, Yue-Yan; Zhang, Ping; Zhu, Shi-Jie; Wang, Fang.
Afiliação
  • Li ZH; Department of Oncology, Wangjing Hospital, China Academy of Chinese Medical Sciences, Beijing 100102, China.
  • Ma YJ; Department of Oncology, Wangjing Hospital, China Academy of Chinese Medical Sciences, Beijing 100102, China.
  • Jia ZH; Department of Oncology, Shandong University of Traditional Chinese Medicine, Jinan 250022, Shandong Province, China.
  • Weng YY; Department of Acupuncture and Moxibustion, Wangjing Hospital, China Academy of Chinese Medical Sciences, Beijing 100102, China.
  • Zhang P; Department of Pathology, Wangjing Hospital, China Academy of Chinese Medical Sciences, Beijing 100102, China.
  • Zhu SJ; Department of Oncology, Wangjing Hospital, China Academy of Chinese Medical Sciences, Beijing 100102, China.
  • Wang F; Department of Oncology, Wangjing Hospital, China Academy of Chinese Medical Sciences, Beijing 100102, China. wf074500@163.com.
World J Clin Cases ; 10(27): 9703-9713, 2022 Sep 26.
Article em En | MEDLINE | ID: mdl-36186177
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Systematic_reviews Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Systematic_reviews Idioma: En Ano de publicação: 2022 Tipo de documento: Article